Cargando…
In vivo data: treatment with the F11R/JAM-A peptide 4D decreases mortality and reduces the generation of atherosclerotic plaques in ApoE-deficient mice
The data in this article focus on the F11 Receptor (F11R/JAM-A; Junctional Adhesion Molecule-A; JAM-A, F11R), a cell adhesion protein constitutively expressed on the membrane surface of circulating platelets and localized within the tight junctions of healthy endothelial cells (ECs). Previous report...
Autores principales: | Babinska, Anna, Clement, Cristina C., Li, Yan, Wzorek, Joanna, Przygodzki, Tomasz, Talar, Marcin, Braun, Marcin, Swiatkowska, Maria, Ehrlich, Yigal H., Kornecki, Elizabeth, Watala, Cezary, Salifu, Moro O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206208/ https://www.ncbi.nlm.nih.gov/pubmed/32395574 http://dx.doi.org/10.1016/j.dib.2020.105516 |
Ejemplares similares
-
Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein
por: Bednarek, Radosław, et al.
Publicado: (2023) -
Intravital Assessment of Blood Platelet Function. A Review of the Methodological Approaches with Examples of Studies of Selected Aspects of Blood Platelet Function
por: Polak, Dawid, et al.
Publicado: (2020) -
Quantification of the Blood Platelet Reactivity in the ADP-Induced Model of Non-Lethal Pulmonary Thromboembolism in Mice with the Use of Laser Doppler Flowmetry
por: Przygodzki, Tomasz, et al.
Publicado: (2016) -
Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines
por: Azari, Bani M, et al.
Publicado: (2011) -
Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y(12) Receptor Antagonists
por: Wolska, Nina, et al.
Publicado: (2019)